RP-6306 is a Protein Kinase, Membrane Associated Tyrosine/Threonine 1 (PKMYT1) inhibitor, which can be used for the research of cancer.
[1] Szychowski J, et al. Compounds, pharmaceutical compositions, and methods of preparing compounds and their use. WO2021195781A1.
















